Financial Enhancement »

Arrowhead Pharmaceuticals shares owned by Financial Enhancement

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Financial Enhancement from 13F filings

Historical chart of Financial Enhancement investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Financial Enhancement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Financial Enhancement

Quarter filed Position value Share count Share price at filing
2025-12-31 $374k 5.5k 67.60

More positions owned by Financial Enhancement

Spdr Series Trust State Street Spd (SPYM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 100 Etf (OEF)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Janus Detroit Str Tr Henderson Securi (JSI)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Ishares Tr Msci Usa Min Vol (USMV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded First Tr Enh New (FTSM)
Victory Portfolios Ii Shares Free Cash (VFLO)
First Tr Exchange-traded Lng Dur Oprtun (LGOV)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)

View all positions for Financial Enhancement

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Geode Capital Management
Slate Path Capital
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Deerfield Management Company
Norges Bank Investment Management
Goldman Sachs Group
Baker Bros. Advisors
Siren
Charles Schwab Investment Management

View all funds holding Arrowhead Pharmaceuticals